Literature DB >> 26384175

Transfemoral TAVI devices: design overview and clinical outcomes.

Mohamed Abdel-Wahab1, John Jose, Gert Richardt.   

Abstract

Over the last decade, transcatheter aortic valve implantation (TAVI) has gained widespread acceptance for the treatment of high surgical risk or inoperable patients with severe aortic stenosis. Spurred on by initial success and an ever-growing body of supporting data, TAVI has undergone rapid technological advancements in recent years with a focus on procedural simplification and limiting complications associated with the early devices. In this article, we provide a brief overview of the past, current and newer devices for transfemoral (TF) TAVI and their post-procedural outcomes.

Entities:  

Mesh:

Year:  2015        PMID: 26384175     DOI: 10.4244/EIJV11SWA33

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  4 in total

1.  Modern Use of Echocardiography in Transcatheter Aortic Valve Replacement: an Up-Date.

Authors:  Cristina Caldararu; Serban Balanescu
Journal:  Maedica (Bucur)       Date:  2016-12

Review 2.  Setting up a transcatheter aortic valve implantation program: Indian perspective.

Authors:  John Jose; Geetesh Manik; Mohamed Abdel-Wahab
Journal:  Indian Heart J       Date:  2016-01-11

3.  Early and mid-term outcomes after transcatheter aortic valve implantation (TAVI) in Ireland.

Authors:  A Bajrangee; J J Coughlan; S Teehan; C O'Connor; R T Murphy; B Foley; C Daly; D Burke; A O Maree; P A Crean
Journal:  Int J Cardiol Heart Vasc       Date:  2017-07-07

4.  Evolution of transcatheter aortic valve implantation over 7 years: results of a prospective single-centre registry of 2000 patients in a large municipal hospital (TAVIK Registry).

Authors:  Gerhard Schymik; Valentin Herzberger; Jens Bergmann; Peter Bramlage; Lars O Conzelmann; Alexander Würth; Armin Luik; Holger Schröfel; Panagiotis Tzamalis
Journal:  BMJ Open       Date:  2018-10-25       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.